戻る
Guangzhou Innogen Pharmaceutical Group Co., Ltd (02591.HK)価格
02591.HK 株価推移チャート
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$27.66
0.94%
$0.26
休場: Feb 16, 12:00:00 HKT
主要データ
前終値
$27.6
始値
$27.4
当日レンジ
$27.04 - $27.7
52週レンジ
$25.5 - $74
取引高
19.6K
平均取引高
1.0M
1株当たり利益(TTM)
-0.55
配当利回り
--
時価総額
$11.6B
INNOGEN-Bとは何ですか？
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.